Wiseguyreports.Com Adds “Infertility Diagnosis and Treatment -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2022” To Its Research Database
The Indian infertility market is anticipated to grow with the CAGR of 12.5% during the period 2017-2022. The major factors that are augmenting the growth of the market are increasing geriatric population in India, Rising alcohol and cigarettes consumption in India. Additionally, rising secondary infertility, increasing penetration of infertility clinics in small towns, growing marriageable age, increasing use of contraceptives are also estimated to be major factors that are driving the growth of infertility diagnosis and treatment market in India.
Alcohol consumption in India is one of the major factors responsible for the infertility in the country. Alcohol consumption in India has risen by 55% during the last two decades. Furthermore, young generation age less than 20 are getting initiated to alcohol much earlier, whereas more women are indulging in binge and hazardous drinking. According to WHO, 30% of the India’s population consume alcohol, out of which 4-15% of them are consumes alcohol daily and about 50% of them are under the hazardous drinking category. Alcohol consumption among female can cause irregular periods, irregular ovulation and can reduce the chances of conception. Therefore the increasing alcohol consumption is estimated to augment the demand of infertility treatment in India.
Increasing geriatric population is also one of the major factors driving the growth of the infertility market in India. In the year 2015, population aging 65 year or older is estimated to account for about 6% of the total population of the India i.e. 78 million, it is further estimated to reach 8.8% by the year 2030. Therefore increasing geriatric population are estimated to fuel the growth of the infertility market in India.
However, there are certain factors that are affecting the growth of the infertility diagnosis and treatment market in India. High cost of treatment, low awareness and lack of trust among people, social stigma related to infertility treatment and lack of regulatory framework and rules and regulation to control the market are the major factors that are hindering the growth of the market in the region.
Key players of the Indian infertility market are Abbott India Limited, Bourn Hall International India Pvt. Ltd., Cadila Healthcare Ltd., Cipla Ltd., Dr. Rama’s Institute for Fertility, GlaxoSmithKline Pharmaceuticals Limited, Moolchand Fertility & IVF, Morpheus Life Sciences Pvt. Ltd., Nova IVI Fertility, Pfizer India, Sun Pharmaceutical Industries Ltd.
1. INDIAN INFERTILITY MARKET BY DIAGNOSIS
1.1. FEMALE INFERTILITY DIAGNOSIS MARKET
1.2. MALE INFERTILITY DIAGNOSIS MARKET
2. INDIAN INFERTILITY MARKET BY TREATMENT
2.1. FEMALE INFERTILITY TREATMENT MARKET
2.2. MALE INFERTILITY TREATMENT MARKET
• Comprehensive research methodology of Indian Infertility Market
• This report also includes detailed and extensive market overview with Analyst insights & key market trends.
• Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting the Indian Infertility Market
• Insights about market determinants which are stimulating the Indian Infertility Market
• Detailed and extensive market segments with regional distribution of forecasted revenues.
• Extensive profiles and recent developments of market players.
Table of Content
1. REPORT SUMMARY
1.1. RESEARCH METHODS AND TOOLS
1.2. MARKET BREAKDOWN
1.2.1. BY SEGMENTS
1.2.2. BY GEOGRAPHY
1.2.3. BY STAKEHOLDERS
2. MARKET OVERVIEW AND INSIGHTS
2.2. ANALYST INSIGHTS & CURRENT MARKET TRENDS
2.2.1. KEY FINDINGS
3. MARKET DETERMINANT
6. COMPANY PROFILES
7.1. ABBOT INDIA LIMITED
7.1.2. ABBOT INDIA LIMITED PRODUCT PORTFOLIO
7.1.3. ABBOT INDIA LIMITED RECENT ACTIVITIES
7.2. BOURN HALL INTERNATIONAL INDIA PVT LTD.
7.2.2. BOURN HALL INTERNATIONAL INDIA PVT LTD. PRODUCT PORTFOLIO
7.2.3. BOURN HALL INTERNATIONAL INDIA PVT LTD. RECENT ACTIVITIES
7.3. CADILA HEALTHCARE LTD.
7.3.2. CADILA HEALTHCARE LTD. PRODUCT PORTFOLIO
7.3.3. CADILA HEALTHCARE LTD. RECENT ACTIVITIES
7.4. CIPLA LTD
7.4.2. CIPLA LTD. PRODUCT PORTFOLIO
7.4.3. CIPLA LTD. RECENT ACTIVITIES
7.5. DR. RAMA’S INSTITUE FOR FERTILITY
7.5.2. DR. RAMA’S INSTITUE FOR FERTILITY PRODUCT PORTFOLIO
7.5.3. DR. RAMA’S INSTITUE FOR FERTILITY RECENT ACTIVITIES
7.6. GLAXOSMITHKLINE PHARMACEUTICALS LIMITED
7.6.2. GLAXOSMITHKLINE PHARMACEUTICALS LIMITED. PRODUCT PORTFOLIO
7.6.3. GLAXOSMITHKLINE PHARMACEUTICALS LIMITED RECENT ACTIVITIES
7.7. MOOLCHAND FERTILITY AND IVF
7.7.2. MOOLCHAND FERTILITY AND IVF PRODUCT PORTFOLIO
7.7.3. MOOLCHAND FERTILITY AND IVF RECENT ACTIVITIES
7.8. MORPHEUS LIFE SCIENCES PVT LTD
7.8.2. MORPHEUS LIFE SCIENCES PVT LTD PRODUCT PORTFOLIO
7.8.3. MORPHEUS LIFE SCIENCES PVT LTD RECENT ACTIVITIES
7.9. NOVA IVI FERTILITY
7.9.2. NOVA IVI FERTILITY PRODUCT PORTFOLIO
7.9.3. NOVA IVI FERTILITY RECENT ACTIVITIES
7.10. SUN PHARMACEUTICALS INDUSTRIES LTD
7.10.2. SUN PHARMACEUTICALS INDUSTRIES LTD PRODUCT PORTFOLIO
7.10.3. SUN PHARMACEUTICALS INDUSTRIES LTD RECENT ACTIVITIES
7.11. PFIZER INDIA
7.11.2. PFIZER INDIA PRODUCT PORTFOLIO
7.11.3. PFIZER INDIA RECENT ACTIVITIES
Contact Us: Sales@Wiseguyreports.Com Ph: +1-646-845-9349 (Us) Ph: +44 208 133 9349 (Uk)
Company Name: Wiseguyreports.com
Contact Person: Norah Trent
Phone: +1 646 845 9349, +44 208 133 9349